NMRD — Nemaura Medical Income Statement
0.000.00%
Last trade - 00:00- $0.00m
- $19.51m
- $0.08m
Annual income statement for Nemaura Medical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0.504 | 0.077 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | 0.16 | 0.002 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 4.48 | 4.78 | 4.59 | 8.07 | 9.67 |
| Operating Profit | -4.48 | -4.78 | -4.59 | -7.57 | -9.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -4.45 | -4.77 | -6.59 | -14.2 | -14.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.45 | -4.16 | -6.26 | -13.9 | -14.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.45 | -4.16 | -6.26 | -13.9 | -14.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.45 | -4.16 | -6.26 | -13.9 | -14.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.246 | -0.2 | -0.281 | -0.594 | -0.47 |